. Author manuscript; available in PMC: 2011 Aug 1.

Published in final edited form as: J Thorac Cardiovasc Surg. 2010 Apr 15;140(2):440–446. doi: 10.1016/j.jtcvs.2010.03.002

Table 3. Pulmonary inflammation at the end of the 120-min reperfusion period.

Group	TNF-α (pg/ml)	MPO Activity (ΔOD/g/min)	Wet/Dry Weight
Control	1336 ± 18.9	0.858 ± 0.012	3.07 ± 0.08
A₁ agonist	759 ± 14.7 ^a^, ^b	0.582 ± 0.013 ^a^, ^b	2.22 ± 0.05 ^a
A₁ agonist + antagonist	1308 ± 18.7 ^b	0.810 ± 0.015 ^b	2.98 ± 0.09 ^b
A_2A agonist	804 ± 17.6 ^a^, ^b	0.482 ± 0.017 ^a^, ^b^, ^c	2.08 ± 0.05 ^a
A_2A agonist + antagonist	1326 ± 18.7 ^b	0.847 ± 0.026 ^b	2.90 ± 0.18 ^b
A₃ agonist	778 ± 10.5 ^a^, ^b	0.540 ± 0.016 ^a^, ^b	2.03 ± 0.08 ^a
A₃ agonist + antagonist	1287 ± 13.8 ^b	0.843 ± 0.150 ^b	3.00 ± 0.06 ^b
Adenosine	978 ± 26.0 ^a	0.697 ± 0.028 ^a	2.41 ± 0.06 ^a

p<0.0002 vs. Control,

p<0.01 vs. Adenosine,

p<0.01 vs. A₁ agonist